Menu

Michael focuses his practice on corporate and securities matters that range from formation, corporate governance and venture-backed financings to mergers & acquisitions and initial and follow-on public offerings. His clients include public companies, venture capital funds and early-stage companies.

Download full bio 

Experience

  • CinCor Pharma to Sell to AstraZeneca for Approximately $1.8 Billion 

  • Horizon Therapeutics to Be Acquired by Amgen for Approximately $28 Billion 

  • Poseida Therapeutics – $80.5 Million Follow-on Offering 

Passions

    Boxing 

    Surfing

    Traveling

Education

  • University of San Diego School of Law
    JD, Corporate Law Concentration
    2021

  • University of California, San Diego
    BS, Human Biology
    2015


Admissions & Credentials

California

Memberships

  • American Bar Association, Young Lawyers Division

Rankings & Accolades

    UCLA Transactional Law Competition: First Place (Best Draft)